{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:40:00Z","timestamp":1740166800039,"version":"3.37.3"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000030","name":"US Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["75D30120C09259"],"award-info":[{"award-number":["75D30120C09259"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We assessed serum neutralization of Omicron BA.5 in children following SARS-CoV-2 infection during the Delta or Omicron BA.1\/BA.2 variant period. Convalescent BA.5 titers were higher following infections during the Omicron BA.1\/BA.2 vs Delta variant period, and in vaccinated vs unvaccinated children. Titers against BA.5 did not differ by age group.<\/jats:p>","DOI":"10.1093\/jpids\/piad109","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T02:45:55Z","timestamp":1703385955000},"page":"100-104","source":"Crossref","is-referenced-by-count":1,"title":["Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-0415","authenticated-orcid":false,"given":"Edward A","family":"Belongia","sequence":"first","affiliation":[{"name":"Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute , Marshfield, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-965X","authenticated-orcid":false,"given":"Joshua G","family":"Petrie","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute , Marshfield, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6760","authenticated-orcid":false,"given":"Leora R","family":"Feldstein","sequence":"additional","affiliation":[{"name":"Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizheng","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin , Madison, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Halfmann","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin , Madison, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer P","family":"King","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute , Marshfield, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin , Madison, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pattinson","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin , Madison, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A","family":"Rolfes","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-6439","authenticated-orcid":false,"given":"Huong Q","family":"McLean","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute , Marshfield, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin , Madison, Wisconsin , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"key":"2024012916025195200_CIT0001","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the delta (B16172) and omicron (B11529) variants\u2014United States, June 2021\u2013January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024012916025195200_CIT0002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7224a2","article-title":"Genomic surveillance for SARS-CoV-2 variants: circulation of omicron lineages\u2014United States, January 2022\u2013May 2023","volume":"72","author":"Ma","year":"2023","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024012916025195200_CIT0003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B11529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"2024012916025195200_CIT0004","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1038\/s41467-022-35312-3","article-title":"BA2 and BA5 omicron differ immunologically from both BA1 omicron and pre-omicron variants","volume":"13","author":"R\u00f6ssler","year":"2022","journal-title":"Nat Commun"},{"key":"2024012916025195200_CIT0005","doi-asserted-by":"crossref","first-page":"e13104","DOI":"10.1111\/irv.13104","article-title":"Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021\u2013July 2022","volume":"17","author":"Petrie","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"2024012916025195200_CIT0006","first-page":"e072065","article-title":"Vaccine effectiveness of primary series and booster doses against COVID-19 associated hospitali admissions in the United States: living test negative study design","volume-title":"BMJ","author":"Adams","year":"2022"},{"key":"2024012916025195200_CIT0007","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.15585\/mmwr.mm7142a3","article-title":"Effectiveness of monovalent mRNA vaccines against COVID-19\u2013associated hospitalization among immunocompetent adults during BA1\/BA2 and BA4\/BA5 predominant periods of SARS-CoV-2 omicron variant in the United States\u2014IVY Network, 18 states, December 26, 2021\u2013August 31, 2022","volume":"71","author":"Surie","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024012916025195200_CIT0008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"2024012916025195200_CIT0009","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/irv.12970","article-title":"mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021","volume":"16","author":"McLean","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"2024012916025195200_CIT0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","article-title":"Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA2","volume":"607","author":"Uraki","year":"2022","journal-title":"Nature"},{"key":"2024012916025195200_CIT0011","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-022-05482-7","article-title":"Characterization of SARS-CoV-2 Omicron BA4 and BA5 isolates in rodents","volume":"612","author":"Uraki","year":"2022","journal-title":"Nature"},{"key":"2024012916025195200_CIT0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 omicron subvariants BA2121, BA4, and BA5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N Engl J Med"},{"key":"2024012916025195200_CIT0013","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.cell.2022.03.019","article-title":"Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants","volume":"185","author":"Servellita","year":"2022","journal-title":"Cell"},{"key":"2024012916025195200_CIT0014","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1473-3099(23)00278-5","article-title":"Virological characteristics of the SARS-CoV-2 omicron XBB116 variant","volume":"23","author":"Yamasoba","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piad109\/54803794\/piad109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/1\/100\/56446659\/piad109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/1\/100\/56446659\/piad109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T16:05:24Z","timestamp":1706544324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/13\/1\/100\/7492786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,23]]},"published-print":{"date-parts":[[2024,1,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piad109","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,12,23]]}}}